Clinical Trials · NCT04175665
Real-world Health Outcomes in Canadian Patients Using Semaglutide
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- LMC Diabetes & Endocrinology Ltd.
- Enrollment
- 1,133
- Start date
- Jan 2020
- Locations
- 1 site, Canada
- Primary endpoint
- Change in HbA1c